ABL Bio Inc. (298380.KQ)
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
66,800.00+0.10%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-4.8%
The outlook
ABL Bio Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 4% of the way from its 52-week low to high, avg target +285% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +285% vs current price
Analyst price target
~12-month · 4 analysts257,500.00average target+285.5% vs now
Now 66,800.00
Low 230,000.00High 280,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.74T
52-wk high
257,500.00
52-wk low
59,800.00
50-day avg
92,494.00
200-day avg
148,415.00
Trailing P/E
—